Join
Live feed
·
PRReleasevia Quantisnow
Kailera Therapeutics Inc. logo

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

ByQuantisnow·Wall Street's wire, on your screen.
KLRA· Kailera Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KLRA (Kailera Therapeutics Inc.) and more on Quantisnow.